Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | ATYR | SNTI | ||
| Company | Cellectis S.A. ADR | Atyr Pharma Inc | Senti Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.06 | 1.7000 | 2.35 | ||
| High | 2.09 | 1.7200 | 2.45 | ||
| Low | 2.04 | 1.5800 | 2.35 | ||
| Last | 2.04 | 1.6900 | 2.38 | ||
| Change | +0.01 | +0.0500 | -0.06 | ||
| % Change | +0.49% | +3.05% | -2.43% | ||
| Volume | 5,013 | 423,473 | 25,303 | ||
| 20-Day Average Volume | 33,626 | 290,777 | 2,276,050 | ||
| Previous Close | 2.03 | 1.6400 | 2.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.00 | 1.6073 | 3.07 | ||
| 20-Day Raw Stochastic | 57.89% | 62.22% | 2.40% | ||
| 20-Day Relative Strength | 42.56% | 49.52% | 40.96% | ||
| Weighted Alpha | -57.76 | -16.01 | -80.67 | ||
| Today's Opinion | 88% Sell | 8% Sell | 96% Sell | ||
| Previous Opinion | 88% Sell | 8% Sell | 96% Sell | ||
| Last Month's Opinion | 56% Sell | 8% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.39% since 07/15/24 | -5.35% since 07/15/24 | -22.52% since 07/15/24 | ||
| Low | 2.02 on 07/19/24 | 1.5800 on 07/22/24 | 2.35 on 07/22/24 | ||
| High | 2.20 on 07/17/24 | 1.7983 on 07/16/24 | 3.11 on 07/16/24 | ||
| 1-Month | |||||
| %Chg | +7.94% since 06/21/24 | +12.11% since 06/21/24 | -6.51% since 06/21/24 | ||
| Low | 1.82 on 06/27/24 | 1.4600 on 06/25/24 | 2.35 on 07/22/24 | ||
| High | 2.20 on 07/17/24 | 1.7983 on 07/16/24 | 6.10 on 07/01/24 | ||
| 3-Month | |||||
| %Chg | -22.73% since 04/22/24 | +1.86% since 04/22/24 | -13.14% since 04/22/24 | ||
| Low | 1.82 on 06/27/24 | 1.4200 on 06/21/24 | 2.11 on 06/03/24 | ||
| High | 3.38 on 05/06/24 | 2.0900 on 05/21/24 | 6.10 on 07/01/24 | ||
| 6-Month | |||||
| %Chg | -25.55% since 01/22/24 | +7.77% since 01/22/24 | -42.17% since 01/22/24 | ||
| Low | 1.82 on 06/27/24 | 1.4200 on 06/21/24 | 2.11 on 06/03/24 | ||
| High | 3.38 on 05/06/24 | 2.1500 on 03/20/24 | 6.10 on 07/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 112,836 | 113,178 | 111,642 | ||
| Shares Outstanding, K | 55,584 | 69,011 | 45,755 | ||
| Annual Sales | 9,190,000 | 350,000 | 2,560,000 | ||
| Annual Net Income | -101,060,000 | -50,390,000 | -71,060,000 | ||
| Last Quarter Sales | 6,500,000 | 240,000 | 0 | ||
| Last Quarter Net Income | 5,640,000 | -15,490,000 | -18,720,000 | ||
| 60-Month Beta | 3.10 | 1.25 | 2.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 05/28/24 | -0.23 on 05/02/24 | -0.26 on 05/09/24 | ||
| Latest Earnings Date | 08/01/24 | 08/14/24 | 08/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||